New: NCI-funded clinical trial search
Mednet Logo
CommunityHematology

For patients with intermediate or lower risk essential thrombocythemia with plt >1000 but no symptoms, do you favor aspirin only therapy or aspirin and cytoreduction?

Recent data without increased cumulative incidence of bleeding in ET patients with plt >1000. Has your practice changed to use cytoreduction less frequently? Have your frequency for monitoring for acquired vWD changed?
Community PollStarted

How do you treat non-high risk ET patients with plt >1000?

18 physicians have voted

Join Mednetto vote and see how they answered.

1 Answer
Mednet MemberInvited Expert
Hematology · Johns Hopkins University
Answered on

First, the wrong question is being asked. The correct question is, what is the proof that the low-risk, intermediate-risk, or high-risk ET classification has any validity? My answer would be that this classification has no validity. Whether it is based on the IPSET scoring system or one of the other new scoring systems is irrelevant since IPSET is really IPETPV because with the WHO diagnostic criteria, PV can't be distinguished from ET, and that is also true for any other ET scoring system and t...

Join for free or sign in to see the full answer